News Immunotherapy Enhances Remission in Relapsed, Refractory Leukemia Promising results from a clinical trial show that CAR-T therapy induces remission in relapsed, refractory leukemia, offering hope for CLL/SLL patients. Read more.
News Scientists Finds Out the Secret behind Long-Lasting Cancer Treatment Cutting-edge research in Nature Medicine unveils the genetic signature of long-lasting CAR T-cells in pediatric leukemia patients, offering insights to enhance cancer treatments and improve long-term effectiveness.
